Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orestis Argyros

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Advances in Genetics|January 27, 2015
Sustained expression from DNA vectorsSuet Ping Wong, Orestis Argyros, Richard P Harbottle
Expert Opinion on Biological Therapy|May 10, 2011
Non-viral episomal modification of cells using S/MAR elementsOrestis Argyros, Suet-Ping Wong, Richard P Harbottle
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2012
Vector systems for prenatal gene therapy: principles of non-viral vector design and productionSuet Ping Wong, Orestis Argyros, Richard P Harbottle
Current Opinion in Molecular Therapeutics|August 4, 2009
Strategies for the episomal modification of cellsSuet Ping Wong, Orestis Argyros, Charles Coutelle, et al.
Molecular Pharmaceutics|January 19, 2017
Gemcitabine Based Peptide Conjugate with Improved Metabolic Properties and Dual Mode of EfficacyTheodoros Karampelas, Eleni Skavatsou, Orestis Argyros, et al.
Plos One|October 31, 2012
Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modellingOrestis Argyros, Suet Ping Wong, Kate Gowers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2011
Systemic gene transfer of polyethylenimine (PEI)-plasmid DNA complexes to neonatal miceSuet Ping Wong, Orestis Argyros, Steven J Howe, et al.
Frontiers in Oncology|April 12, 2021
Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast CancerIoanna-Maria Orfanou, Orestis Argyros, Andreas Papapetropoulos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2013
Examination of the effect of increasing the number of intra-disulfide amino functional groups on the performance of small molecule cyclic polyamine disulfide vectorsChristopher R Drake, Abderrahim Aissaoui, Orestis Argyros, et al.
European Journal of Medicinal Chemistry|December 23, 2016
Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activityOrestis Argyros, Nikolaos Lougiakis, Eva Kouvari, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Advances in Genetics|January 27, 2015
Sustained expression from DNA vectorsSuet Ping Wong, Orestis Argyros, Richard P Harbottle
Expert Opinion on Biological Therapy|May 10, 2011
Non-viral episomal modification of cells using S/MAR elementsOrestis Argyros, Suet-Ping Wong, Richard P Harbottle
Methods in Molecular Biology (Clifton, N.J.)|June 1, 2012
Vector systems for prenatal gene therapy: principles of non-viral vector design and productionSuet Ping Wong, Orestis Argyros, Richard P Harbottle
Current Opinion in Molecular Therapeutics|August 4, 2009
Strategies for the episomal modification of cellsSuet Ping Wong, Orestis Argyros, Charles Coutelle, et al.
Molecular Pharmaceutics|January 19, 2017
Gemcitabine Based Peptide Conjugate with Improved Metabolic Properties and Dual Mode of EfficacyTheodoros Karampelas, Eleni Skavatsou, Orestis Argyros, et al.
Plos One|October 31, 2012
Genetic modification of cancer cells using non-viral, episomal S/MAR vectors for in vivo tumour modellingOrestis Argyros, Suet Ping Wong, Kate Gowers, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 4, 2011
Systemic gene transfer of polyethylenimine (PEI)-plasmid DNA complexes to neonatal miceSuet Ping Wong, Orestis Argyros, Steven J Howe, et al.
Frontiers in Oncology|April 12, 2021
Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast CancerIoanna-Maria Orfanou, Orestis Argyros, Andreas Papapetropoulos, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 5, 2013
Examination of the effect of increasing the number of intra-disulfide amino functional groups on the performance of small molecule cyclic polyamine disulfide vectorsChristopher R Drake, Abderrahim Aissaoui, Orestis Argyros, et al.
European Journal of Medicinal Chemistry|December 23, 2016
Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activityOrestis Argyros, Nikolaos Lougiakis, Eva Kouvari, et al.
Pageof 2